A. Laughlin

Statistics

Publications

Citations

102

H-Index

Active since

1986

Affiliations

University of Toronto(Current)

A. Laughlin is an author at University of Toronto specializing in oncology pharmacotherapy, hospital cost accounting, and pharmacodynamics of anticancer drugs.

Publications per year

1986–2011

Publications

Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours

A.R. Abdul Razak, Sebastién J. Hotte, Lillian L. Siu et al. · British Journal of Cancer · 2011 · 66 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Source of admission and cost: public hospitals face financial risk.

Eric Muñoz, R Soldano, A. Laughlin et al. · American Journal of Public Health · 1986 · 36 citations · Full text

Health Professions, Health Administration, Health Services Administration +17

1–2 of 2